Meropenem Navamedic

Meropenem, the active ingredient in Meropenem Navamedic, is a carbapenem antibiotic presented as a sterile powder for intravenous use. It is employed to treat severe bacterial infections, including intra‑abdominal, urinary tract, respiratory, bloodstream, and central nervous system infections in hospitalized patients.

GNH USA supplies Meropenem Navamedic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product meets EU market standards and is manufactured under strict quality controls.

Meropenem is a carbapenem antibiotic used for serious bacterial infections affecting various organ systems.

- Complicated intra‑abdominal infections: provides broad‑spectrum coverage against Gram‑negative, Gram‑positive and anaerobic pathogens. - Complicated urinary tract infections: eradicates resistant uropathogens causing pyelonephritis and cystitis. - Nosocomial pneumonia: treats hospital‑acquired and ventilator‑associated pneumonia caused by multidrug‑resistant bacteria. - Septicemia: rapidly clears bloodstream infections with susceptible organisms. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: localized skin erythema or pruritus. - Headache: transient and usually resolves without intervention.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or high doses. - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile‑associated diarrhea: can be life‑threatening. - Thrombocytopenia or neutropenia: marked reduction in blood cell counts. - Renal impairment: worsening kidney function in susceptible individuals. - Hepatic enzyme elevation: abnormal liver function tests.

Meropenem should be used with caution in specific clinical situations. - Renal function: adjust dose in patients with impaired renal clearance. - Seizure risk: monitor patients with central nervous system disorders or receiving high doses. - Allergy: avoid in patients with known hypersensitivity to carbapenems or other β‑lactam antibiotics. - Pregnancy: use only if benefits outweigh potential risks; safety data are limited. - Drug interactions: review concomitant medications for potential interactions. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with several medicines; clinical judgment is required.

Major Interactions (Avoid): - Valproic acid: may reduce serum levels, increasing seizure risk. - Probenecid: can raise meropenem concentrations, heightening toxicity. - High‑dose aminoglycosides: additive nephrotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: may enhance nephrotoxic potential. - Anticoagulants (e.g., warfarin): possible alteration of INR. - Oral contraceptives: may experience reduced efficacy. - Other β‑lactam antibiotics: potential for antagonistic effects.